Rexahn Pharmaceuticals, Inc. (NASDAQ: REXN) is making a run for the top in the market today, trading on gains of more than 10%. The gains come after the company announced that it would be moving forward with strategic alternatives.
In the announcement, REXN said that it is now in the process of exploring strategic alternatives with the goal of enhancing shareholder value. In order to do so, the company has engaged Oppenheimer $ Co., Inc. as its financial advisor.
Here are three reasons that investors are so excited to hear about the strategic exploration:
Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!
Reason #1: A Potential Buyout Of REXN Could Be The Result
When outlining the opportunities that the company is exploring, Rexahn Pharmaceuticals said that it would be looking into a potential acquisition, merger,reverse merger, or other business combination.
Should an acquisition take place, there’s a strong chance that it would happen at a premium to the market cap that we see on the stock. Let’s face it, one of the biggest catalystic events that can happen to a stock is the stock being acquired.
Knowing that REXN is actively looking for acquisition, merger, reverse merger, and other business combination opportunities suggests that a highly accretive transaction may take place relatively soon.